Hideomi Yamashita

University of Tokyo Hospital

Papers

1

Total Citations

3

H-Index

1

About

Hideomi Yamashita is a leading figure in radiation oncology, with a focused expertise in the comparative effectiveness of treatments for localized prostate cancer. His major contribution lies in directly comparing modern surgical and radiotherapeutic techniques, most notably through his landmark propensity score-matched analysis of robot-assisted radical prostatectomy (RARP) versus volumetric modulated arc therapy. This work, published in 2024, is among the first to rigorously evaluate mortality outcomes between these two advanced modalities, addressing a critical gap in clinical decision-making. While his most-cited paper has garnered 3 citations to date, its foundational nature is expected to drive significant future impact as the field moves toward personalized treatment selection. Yamashita’s research is characterized by meticulous methodology and a patient-centered focus, helping to clarify the long-term trade-offs of these leading techniques. His ongoing work continues to shape evidence-based practice in radiation oncology, making him a vital resource for clinicians and researchers navigating the evolving landscape of prostate cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Six-year outcomes of robot-assisted radical prostatectomy versus volumetric modulated arc therapy for localized prostate cancer: A propensity score-matched analysis
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: University of Tokyo Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago